|
Volumn 35, Issue 3, 2008, Pages 135-153
|
Anti-inflammatory therapies for cystic fibrosis-related lung disease.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
CORTICOSTEROID;
IBUPROFEN;
AIRWAY OBSTRUCTION;
CLINICAL TRIAL;
CYSTIC FIBROSIS;
HUMAN;
PATHOPHYSIOLOGY;
PNEUMONIA;
RESPIRATORY TRACT INFECTION;
REVIEW;
SIGNAL TRANSDUCTION;
ADRENAL CORTEX HORMONES;
AIRWAY OBSTRUCTION;
ANTI-INFLAMMATORY AGENTS;
CLINICAL TRIALS AS TOPIC;
CYSTIC FIBROSIS;
HUMANS;
IBUPROFEN;
PNEUMONIA;
RESPIRATORY TRACT INFECTIONS;
SIGNAL TRANSDUCTION;
|
EID: 59449089139
PISSN: 10800549
EISSN: None
Source Type: Journal
DOI: 10.1007/s12016-008-8081-2 Document Type: Review |
Times cited : (35)
|
References (183)
|